Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Insulin Archives
Print | Email | Share | Comments (0)

Network to Focus on Type 1 Prevention


Feb 1, 2003

Fourteen entities have joined forces to form Type 1 Diabetes TrialNet, a collaborative effort to test new approaches to understanding, preventing and treating type 1 diabetes. Recruitment for the first trials is expected to begin in early 2003.

Prevention trials will attempt to stop or delay the destruction of insulin-producing beta cells in people at risk for type 1 diabetes. Treatment trials will try to preserve remaining beta cells in those with new-onset type 1 diabetes.

"TrialNet will expedite the application of discoveries in basic research to therapies that benefit people with type 1 diabetes and those at risk," says Jay Skyler, MD, of the University of Miami.

Skyler, who is the study chair for TrialNet, oversaw the Diabetes Prevention Trial Type 1 (DPT-1). DPT-1 had two components: a low-dose insulin injection trial that ended in 2001 after discovering that the injections failed to prevent type 1 diabetes; and an oral insulin trial, which will become part of the new TrialNet.

"Mounting individual trials for prevention of type 1 diabetes is a challenging, costly endeavor," says Allen Spiegel, MD, director of the National Institute of Diabetes and Digestive and Kidney Diseases, which leads the initiative. "This network provides a stable, efficient, cost-effective system for identifying people at risk for type 1 diabetes and testing the ability of promising new agents to prevent the disease."

For more information about TrialNet, call (800) 425-8361.


Categories: Diabetes, Diabetes, Insulin, Support Groups, Type 1 Issues, Type 1 Issues



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.